PEPTIDE-OLIGOUREA FOLDAMER COMPOUNDS AND METHODS OF THEIR USE
The present description provides compositions and methods for producing therapeutic compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medic...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZIMMER, ROBERT GOUDREAU, SEBASTIEN |
| description | The present description provides compositions and methods for producing therapeutic compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the present disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.
La présente invention concerne des compositions et des procédés permettant de produire des composés thérapeutiques. Dans un autre aspect, l'invention concerne des procédés d'administration de ces composés oligomères à des fins de traitement et de prévention d'une maladie chez un mammifère. En particulier, l'invention concerne des médicaments comprenant divers nouveaux composés oligomères et leurs sels pharmaceutiquement acceptables. Les composés de l'invention peuvent éventuellement être administrés avec un excipient pharmaceutiquement acceptable et/ou un principe pharmacologiquement actif supplémentaire, ou une combinaison de ceux-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3021140A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3021140A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3021140A13</originalsourceid><addsrcrecordid>eNrjZLANcA0I8XRx1fX38XT3Dw1ydVRw8_dxcfR1DVJw9vcN8A_1cwlWcPRzUfB1DfHwB7L93RRCPFw9gxRCg115GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8s6OxgZGhoYmBo6ExEUoA2j0pJg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PEPTIDE-OLIGOUREA FOLDAMER COMPOUNDS AND METHODS OF THEIR USE</title><source>esp@cenet</source><creator>ZIMMER, ROBERT ; GOUDREAU, SEBASTIEN</creator><creatorcontrib>ZIMMER, ROBERT ; GOUDREAU, SEBASTIEN</creatorcontrib><description>The present description provides compositions and methods for producing therapeutic compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the present disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.
La présente invention concerne des compositions et des procédés permettant de produire des composés thérapeutiques. Dans un autre aspect, l'invention concerne des procédés d'administration de ces composés oligomères à des fins de traitement et de prévention d'une maladie chez un mammifère. En particulier, l'invention concerne des médicaments comprenant divers nouveaux composés oligomères et leurs sels pharmaceutiquement acceptables. Les composés de l'invention peuvent éventuellement être administrés avec un excipient pharmaceutiquement acceptable et/ou un principe pharmacologiquement actif supplémentaire, ou une combinaison de ceux-ci.</description><language>eng ; fre</language><subject>CHEMISTRY ; COMPOSITIONS BASED THEREON ; COMPOSITIONS OF MACROMOLECULAR COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; ORGANIC MACROMOLECULAR COMPOUNDS ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; TESTING ; THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171026&DB=EPODOC&CC=CA&NR=3021140A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171026&DB=EPODOC&CC=CA&NR=3021140A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZIMMER, ROBERT</creatorcontrib><creatorcontrib>GOUDREAU, SEBASTIEN</creatorcontrib><title>PEPTIDE-OLIGOUREA FOLDAMER COMPOUNDS AND METHODS OF THEIR USE</title><description>The present description provides compositions and methods for producing therapeutic compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the present disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.
La présente invention concerne des compositions et des procédés permettant de produire des composés thérapeutiques. Dans un autre aspect, l'invention concerne des procédés d'administration de ces composés oligomères à des fins de traitement et de prévention d'une maladie chez un mammifère. En particulier, l'invention concerne des médicaments comprenant divers nouveaux composés oligomères et leurs sels pharmaceutiquement acceptables. Les composés de l'invention peuvent éventuellement être administrés avec un excipient pharmaceutiquement acceptable et/ou un principe pharmacologiquement actif supplémentaire, ou une combinaison de ceux-ci.</description><subject>CHEMISTRY</subject><subject>COMPOSITIONS BASED THEREON</subject><subject>COMPOSITIONS OF MACROMOLECULAR COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>ORGANIC MACROMOLECULAR COMPOUNDS</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>TESTING</subject><subject>THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLANcA0I8XRx1fX38XT3Dw1ydVRw8_dxcfR1DVJw9vcN8A_1cwlWcPRzUfB1DfHwB7L93RRCPFw9gxRCg115GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8s6OxgZGhoYmBo6ExEUoA2j0pJg</recordid><startdate>20171026</startdate><enddate>20171026</enddate><creator>ZIMMER, ROBERT</creator><creator>GOUDREAU, SEBASTIEN</creator><scope>EVB</scope></search><sort><creationdate>20171026</creationdate><title>PEPTIDE-OLIGOUREA FOLDAMER COMPOUNDS AND METHODS OF THEIR USE</title><author>ZIMMER, ROBERT ; GOUDREAU, SEBASTIEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3021140A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>COMPOSITIONS BASED THEREON</topic><topic>COMPOSITIONS OF MACROMOLECULAR COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>ORGANIC MACROMOLECULAR COMPOUNDS</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>TESTING</topic><topic>THEIR PREPARATION OR CHEMICAL WORKING-UP</topic><toplevel>online_resources</toplevel><creatorcontrib>ZIMMER, ROBERT</creatorcontrib><creatorcontrib>GOUDREAU, SEBASTIEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZIMMER, ROBERT</au><au>GOUDREAU, SEBASTIEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PEPTIDE-OLIGOUREA FOLDAMER COMPOUNDS AND METHODS OF THEIR USE</title><date>2017-10-26</date><risdate>2017</risdate><abstract>The present description provides compositions and methods for producing therapeutic compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the present disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.
La présente invention concerne des compositions et des procédés permettant de produire des composés thérapeutiques. Dans un autre aspect, l'invention concerne des procédés d'administration de ces composés oligomères à des fins de traitement et de prévention d'une maladie chez un mammifère. En particulier, l'invention concerne des médicaments comprenant divers nouveaux composés oligomères et leurs sels pharmaceutiquement acceptables. Les composés de l'invention peuvent éventuellement être administrés avec un excipient pharmaceutiquement acceptable et/ou un principe pharmacologiquement actif supplémentaire, ou une combinaison de ceux-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3021140A1 |
| source | esp@cenet |
| subjects | CHEMISTRY COMPOSITIONS BASED THEREON COMPOSITIONS OF MACROMOLECULAR COMPOUNDS HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY ORGANIC MACROMOLECULAR COMPOUNDS PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES TESTING THEIR PREPARATION OR CHEMICAL WORKING-UP |
| title | PEPTIDE-OLIGOUREA FOLDAMER COMPOUNDS AND METHODS OF THEIR USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T04%3A21%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZIMMER,%20ROBERT&rft.date=2017-10-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3021140A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |